Category: BiometSyndicate content

ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A

December 10, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Zimmer proposes to mollify European anti-trust regulators on its pending, $13 billion acquisition of rival Biomet by selling off some of its knee and elbow assets in Europe.

Zimmer proposes divestitures for EU regulators in Biomet deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

EU, Zimmer agree to extend review of Biomet merger

November 18, 2014 by Brad Perriello

Zimmer says it agreed with the European Commission to extend the EuroZone review of its pending, $13.4 billion acquisition of cross-town orthopedics rival Biomet.

EU, Zimmer agree to extend review of Biomet merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A

November 5, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

SNN wins another patent spat with Arthrex | Medtech legal news for the week of November 3, 2014

November 3, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Smith & Nephew claims another win in patent spat with Arthrex; Biomet inks $6m deal to settle kickback charges; Insurer owes Stryker $8m for Duracon Uni-Knee settlements

Smith & Nephew claims another win in patent spat with Arthrex

October 27, 2014 by Brad Perriello

Zimmer reveals post-Biomet merger plans

October 31, 2014 by Brad Perriello

Zimmer reveals the management team and business structure it plans to put in place once its $13 billion merger with rival Biomet closes.

Zimmer reveals post-Biomet merger plans

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biomet inks $6m deal to settle kickback charges

October 29, 2014 by Brad Perriello

Biomet agrees to pay more than $6 million to settle False Claims Act charges that it paid doctors to use its bone-growth stimulators.

Biomet inks $6m deal to settle FCA charges

Biomet paid nearly $6.1 million to settle federal charges that it paid kickbacks to doctors to induce them to use bone growth stimulators sold by its EBI subsidiary, the U.S. Justice Dept. said today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp